IRIS - Res&Arch Institutional Research Information System - Research & Archive

IORIO, Alfonso
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.817
EU - Europa 9.510
AS - Asia 8.750
SA - Sud America 1.754
AF - Africa 216
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 15
Totale 33.087
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.303
SG - Singapore 4.134
IE - Irlanda 1.766
UA - Ucraina 1.712
RU - Federazione Russa 1.557
BR - Brasile 1.373
HK - Hong Kong 1.336
IT - Italia 993
CN - Cina 989
SE - Svezia 868
VN - Vietnam 851
DE - Germania 617
FR - Francia 562
FI - Finlandia 550
CA - Canada 373
GB - Regno Unito 369
KR - Corea 272
IN - India 190
TR - Turchia 189
BD - Bangladesh 133
AR - Argentina 121
IQ - Iraq 100
PL - Polonia 84
UZ - Uzbekistan 83
MX - Messico 77
CH - Svizzera 69
AT - Austria 68
EC - Ecuador 68
CO - Colombia 60
ID - Indonesia 58
PK - Pakistan 58
NL - Olanda 57
ZA - Sudafrica 55
JP - Giappone 52
SA - Arabia Saudita 51
PH - Filippine 41
ES - Italia 35
LB - Libano 33
VE - Venezuela 33
CZ - Repubblica Ceca 32
PY - Paraguay 31
RO - Romania 30
BE - Belgio 29
MA - Marocco 27
TN - Tunisia 26
CL - Cile 23
GR - Grecia 23
AE - Emirati Arabi Uniti 22
KE - Kenya 22
LT - Lituania 21
PE - Perù 21
PT - Portogallo 21
EG - Egitto 20
JO - Giordania 19
MY - Malesia 19
NP - Nepal 19
AU - Australia 17
DZ - Algeria 14
EU - Europa 14
DO - Repubblica Dominicana 13
UY - Uruguay 13
OM - Oman 12
BG - Bulgaria 11
KZ - Kazakistan 11
BO - Bolivia 10
ET - Etiopia 10
AM - Armenia 9
JM - Giamaica 9
CR - Costa Rica 8
HN - Honduras 8
SN - Senegal 8
TW - Taiwan 8
IL - Israele 7
PA - Panama 7
BH - Bahrain 6
NZ - Nuova Zelanda 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
KG - Kirghizistan 5
NI - Nicaragua 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
BF - Burkina Faso 4
GE - Georgia 4
HU - Ungheria 4
LU - Lussemburgo 4
PS - Palestinian Territory 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CY - Cipro 3
DK - Danimarca 3
GA - Gabon 3
MN - Mongolia 3
NG - Nigeria 3
QA - Qatar 3
RS - Serbia 3
TH - Thailandia 3
AF - Afghanistan, Repubblica islamica di 2
BB - Barbados 2
Totale 33.034
Salva come PNG Salva come JPEG
Città #
Singapore 2.753
Dublin 1.764
Chandler 1.691
Hong Kong 1.329
San Mateo 1.102
San Jose 954
Jacksonville 769
Boardman 657
Ashburn 554
Santa Clara 530
Dong Ket 489
Medford 489
Princeton 486
Moscow 468
Lauterbourg 425
Wilmington 368
Altamura 362
Andover 345
Lawrence 283
Perugia 272
Seoul 268
Ottawa 267
Ann Arbor 242
Beijing 162
Ho Chi Minh City 141
Des Moines 139
New York 139
São Paulo 138
Saint Petersburg 130
Los Angeles 123
Piscataway 117
The Dalles 110
Norwalk 108
Izmir 106
Helsinki 94
Shanghai 86
Munich 84
Columbus 67
Hanoi 67
Rio de Janeiro 57
Dallas 55
Falls Church 55
San Paolo di Civitate 54
Orem 46
Warsaw 46
Brooklyn 43
Baghdad 42
Chicago 42
London 42
Tokyo 42
Frankfurt am Main 38
Montreal 38
Woodbridge 38
Chennai 35
Tashkent 35
Nuremberg 34
Turku 33
Belo Horizonte 32
Brasília 31
Johannesburg 31
Redwood City 31
Milan 30
Phoenix 29
Brussels 28
Houston 28
Rome 28
Amelia 25
Stockholm 25
Guangzhou 24
San Diego 24
San Francisco 24
Atlanta 23
Amsterdam 22
Bogotá 22
Dearborn 22
Salvador 22
Boston 21
Bucharest 21
Curitiba 21
Denver 21
Goiânia 21
Jeddah 21
Lahore 21
Manchester 21
Redmond 21
Council Bluffs 20
Guayaquil 20
Istanbul 20
Quito 20
Ankara 19
Den Haag 19
Ribeirão Preto 19
Auburn Hills 18
Frankfurt Am Main 18
Mexico City 18
Nairobi 18
Amman 17
Dhaka 17
Porto Alegre 17
Vienna 17
Totale 20.420
Salva come PNG Salva come JPEG
Nome #
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 190
Interventions for enhancing medication adherence. 161
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 161
1286 Prospective consecutive cases of venous thromboembolic diseases at the single Venous thromboembolic Unit of Reggio Emilia 160
Oral anticoagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS) 149
Serine base exchange enzyme in commercially available porcine lyophilised platelets: different effect of unfractionated and low molecular weight heparins 130
Acute ketoacidosisin continuous subcutaneous insulin infusion treated Type 1 diabetics impairs the fibrynolytic capacity 129
Establishing the prevalence and prevalence at birth of hemophilia in males a meta-analytic approach using national registries 129
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 128
Development and validation of the first treatment satisfaction scale for adult haemophiliacs (Hemo0-SatA) 128
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial 127
. The role of thrombophilic states in the bleeding tendency of patients with hemophilia 126
Influenza vaccination in patients on long-term anticoagulant therapy 123
Influenza vaccination in patients on long-term anticoagulant therapy. 122
A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation 120
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 119
Sindrome da anticorpi fosfolipidi. Descrizione di un caso clinico con trombosi atriale dx e revisione della casistica di Reggio Emilia 116
A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol. 115
Sustained suppression of hepatitics C by pegylated Interferon (PEG-INF) and Ribavirin in hemophilic patients 111
OAT with POC devices and remote computer monitoring in the setting of the Italian NHS: a controlled clinical trial 111
Answering relevant research questions via careful observation of clinical practice: a fresh look at the old way forward. 111
LMWH or Ximelagatran versus VKA in the prevention of VTE after major knee surgery: a meta-analysis of randomized controlled trials 110
Thrombophilia and cerebral vein thrombosis 110
Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase. 110
Systematic Review of Randomized Controlled Trials of Prophilactic Clotting Factor Concentrate in Hemophilia 109
Audit clinico sull’impiego di plasma fresco congelato (PFC) in Umbria: disegno dello studio e risultati preliminari. 109
A Predictive Model for the Development of High-Responding Inhibitor In Children with Severe and Moderate Hemophilia A- Results of a Multicenter Cohort Study. 109
Low-molecular-weight-heparin for the long term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulant 107
ACP Journal Club. A 9-factor score predicted 2-year risk for bleeding in outpatients with, or at high risk for, atherothrombosis. 107
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors. 107
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism 106
Audit of the clinical use of fresh-frozen plasma in umbria: study design and results. 106
L’organizzazione del centro per il monitoraggio della terapia anticoagulante orale 105
I disordini congeniti ed acquisiti dell’emostasi e della fibrinolisi 104
Le trombofilie acquisite 103
Prothrombin 202120A mutation in Behcet’s disease 103
Il monitoraggio della terapia anticoagulante orale 103
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation. 103
Effect of dermatan sulphate on activated partial thromboplastin time determined with different reagents 102
Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study. 102
D-DIMER TO PREDICT THROMBOSIS RECURRENCE: COMPARISON OF AGGREGATE DATA AND INDIVIDUAL PATIENT DATA META-ANALYSES. 102
Defective indoleamine 2,3-dioxygenase induction is associated with inhibitor development in severe hemophilia a patients carrying f8 gene null mutations. 102
Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen 102
Low-molecular-weight heparin treatment and cancer: pooled analysis of 908 patients treated for three months 100
D-DIMER TO PREDICT RECURRENCE AFTER A FIRST EPISODE OF UNPROVOKED VENOUS THROMBOEMBOLISM: COMPARISON OF AGGREGATE AND INDIVIDUAL PATIENT DATA META-ANALYSIS 100
Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls 100
Venous thromboembolic disease: clinical reatures of 1282 prospective consecutive cases at angiology unit of Reggio Emilia 99
The good use of plasma. A critical analysis of five international guidelines. 99
Bayesian approach to the assessment of the population-specific risk of inhibitors in hemophilia A patients: a case study 99
IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY 97
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No 97
D-DIMER TO PREDICT THROMBOSIS RECURRENCE AFTER UNPROVOKED VENOUS THROMBOEMBOLISM: EFFECT OF PATIENT- AND D-DIMER-RELATED FACTORS ON RECURRENCE PREDICTION 97
Experimental evidences on the role of silica nanoparticles surface morphology on the loading, release and activity of three proteins 97
A comparison of methods for prediction of pharmacokinetics across factor concentrate switching in hemophilia patients 97
Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project 97
APTT evaluation in the presurgery screening: survey of 5000 patients 96
Studio GEMINA: ruolo dei polimorfismi genetici e dell'omocisteinemia nell'infarto del miocardico in giovani-adulti italiani 96
Acute ketoacidosisin continuous subcutaneous insulin infusion treated Type 1 diabetics impairs the fibrynolytic capacity 96
Ecaps study: multicentric evaluation of cerebral hemorrhage in anticoagulated/antiaggregated patients in the italian emergency rooms 95
Profilassi della trombosi venosa profonda in neurochirurgia 95
Switching patients in the age of long-acting recombinant products? 95
Prolonged antithrombin activity of low-molecular-weight heparins. Clinical implications for the treatment of thromboembolic diseases 94
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders. 94
Risk factors for venous thromboembolism in patients undergoing elective neurosurgery 93
Impairment of fibrynolytic capacity in experimentally induced ketoacidosis in continuous subcutaneous insulin infusion patients 93
ACP Journal Club. The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care. 93
A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews 93
Elderly patients treated with oral anticoagulant: a prospective cohort study 92
Eradicazione del virus C dell'epatite (HCV) dopo terapia combinata con Interferone Pegilato (PEG-INF) e Rivabirina in pazienti emofilici HIV negativi 92
Different mechanism regulate phosphatidylserine synthesis in rat cerebral cortex" 92
Critical appraisal of five international guidelines on fresh frozen plasma clinical use. 92
Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A 92
Low molecular weight heparin for prevention of venous thromboembolism in elective neurosurgery: a metanalysis 91
Terapia anticoagulante orale con l’impiego di tecnologia POC e monitoraggio via web nell’ambito del Sistema Sanitario Nazionale Italiano 91
Clinical and laboratoristic performance evaluation of three point-of-care devices for INR determination (Coagucheck, ProTime, Harmony) 91
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis. 91
D-Dimer Testing to Determine the Duration of Anticoagulation Therapy 91
Clinical audit of the use of fresh frozen plasma in Umbria: study design and results of the pilot phase. 91
A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease 91
Genima study: genetic polymorphysms and myocardial infarction among italian young adults 90
ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C IN HEMOPHILIA PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS 90
Bioequivalence of B-domain deleted and plasma derived FVIII concentrates. 90
GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks 90
The association between platelet transfusions and mortality in patients with critical illness 90
Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis 89
Gemina study:genetic polymorphysms and myocardial infarction among italian young adults 89
HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY 89
Prospective assessment of clinical endpoints of vka treatment in a primary care computer assisted management model. 89
The association between venous thromboembolism and physical inactivity in everyday life 89
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 89
ANTITHROMBOTIC PROPHYLAXIS IN ELDERLY PATIENTS ATRIAL FIBRILLATION ADMITTED TO INTERNAL MEDICINE WARDS IN ITALY: ADHERENCE TO GUIDELINES 89
Pharmacokinetics of plasma-derived vs. recombinant FVIII concentrates: a comparative study. 89
Pharmacoeconomic evaluation of the management of oral anticoagulant treatment with point-of-care devices in the Italian national health care system 88
Heparin reduces venous thromboembolism in neurosurgery but increases the risk of bleeding. (Iorio A, Agnelli G. Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a metanalysis. Arch Intern Med. 2000;160:2327-2332) 88
Factor V Leiden and G20210A prothrombin allele are not associated with thrombosis in Behcet’s disease 88
Low-molecular-weight-heparin for the long term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparison with oral anticoagulant 88
Thrombotic risk and laboratory pattern in 91 consecutive patients with lupus anticoagulant and/or anticardiolipin antibodies 88
Hyperhomcysteinemia and other thrombophilic factors in Italian patients with inflammatory bowel disease 88
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 88
RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS 88
Totale 10.362
Salva come PNG Salva come JPEG
Categoria #
all - tutte 157.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.530
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021785 0 0 0 0 0 0 0 0 0 0 247 538
2021/20223.740 51 742 92 140 123 36 64 1.372 34 25 445 616
2022/20235.912 541 887 95 415 472 660 8 302 2.251 10 193 78
2023/20242.084 157 229 108 36 36 14 507 125 211 82 238 341
2024/20255.072 20 621 63 140 714 106 88 419 1.145 344 1.009 403
2025/202610.150 786 573 628 1.433 1.025 1.040 1.961 581 1.029 901 193 0
Totale 33.793